Michele Ann Weidner-Wells

Title: Michele Ann Weidner-Wells: Innovator in Pharmaceutical Science

Introduction

Michele Ann Weidner-Wells is a prominent inventor based in Hillsborough, NJ (US). She has made significant contributions to the field of pharmaceutical science, holding a total of seven patents. Her work primarily focuses on developing innovative compounds that address various medical conditions.

Latest Patents

Among her latest patents is the invention of α-ketoamide derivatives useful as endothelial lipase inhibitors. This invention is directed towards pharmaceutical compositions containing these derivatives and their application in treating disorders modulated by endothelial lipase, particularly cardiovascular disorders. Another notable patent involves C-7 isoxazolinyl quinolone/naphthyridine derivatives, which are recognized for their potential as antibacterial agents. This invention relates to antimicrobial compounds and their use against pathogenic microorganisms, especially resistant microbes.

Career Highlights

Michele has worked with reputable companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Throughout her career, Michele has collaborated with notable professionals in her field, including Dennis J. Hlasta and Mark J. Macielag. These collaborations have further enhanced her research and development efforts.

Conclusion

Michele Ann Weidner-Wells is a distinguished inventor whose work in pharmaceutical science has led to significant advancements in medical treatments. Her innovative patents and collaborations reflect her commitment to improving healthcare through scientific research.